Your session is about to expire
← Back to Search
Calibration of MR and PET-MR Imaging Protocols for Imaging
N/A
Recruiting
Led By Daniel S. Berman, M.D.
Research Sponsored by Cedars-Sinai Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Age ≥18 years.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day
Awards & highlights
Study Summary
This trial is to help with the technical aspects of the Siemens Biograph mMR and 3T Siemens Vida MR scanner.
Who is the study for?
This trial is for adults over 18 years old. For PET-MR imaging, it's for outpatients already getting a standard 18FDG-PET scan at CSMC. For MR-only imaging, it's open to volunteers responding to ads from the BIRI Research Imaging Core. Pregnant individuals or those with contraindications to MRI (like metallic implants or severe claustrophobia) cannot participate.Check my eligibility
What is being tested?
The study is calibrating two types of scanners: the Siemens Biograph mMR scanner for combined PET-MR images and the Siemens Vida 3T MR scanner for MR images only. These are non-experimental FDA-approved devices used according to federal guidelines.See study design
What are the potential side effects?
Since this trial involves standard imaging procedures that are non-invasive and use approved equipment, significant side effects are not expected. However, typical MRI-related discomforts like loud noises during scanning or issues related to lying still may occur.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Positron-Emission Tomography
Trial Design
3Treatment groups
Experimental Treatment
Group I: PET-MR imaging on Biograph mMR scannerExperimental Treatment1 Intervention
Research PET-MR imaging on Biograph mMR scanner will be conducted immediately following administration of FDG for clinically approved scan. No additional radioisotope will be administered for the research scan.
Group II: MR-only imaging on Biograph mMR scannerExperimental Treatment1 Intervention
Participants will undergo research MR-only imaging on Biograph mMR scanner.
Group III: MR imaging on the Siemens Vida 3T MR scannerExperimental Treatment1 Intervention
Participants will undergo research MR imaging on the Siemens MR scanner
Find a Location
Who is running the clinical trial?
Cedars-Sinai Medical CenterLead Sponsor
500 Previous Clinical Trials
164,823 Total Patients Enrolled
22 Trials studying Coronary Artery Disease
17,387 Patients Enrolled for Coronary Artery Disease
Daniel S. Berman, M.D.5.02 ReviewsPrincipal Investigator - Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
1 Previous Clinical Trials
2,137 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
2,137 Patients Enrolled for Coronary Artery Disease
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are getting a standard PET scan at a specific medical center.I am 18 years old or older.I am under 18 years old.People who have responded to an advertisement to volunteer for research MR at BIRI Research Imaging Core are not eligible.
Research Study Groups:
This trial has the following groups:- Group 1: PET-MR imaging on Biograph mMR scanner
- Group 2: MR-only imaging on Biograph mMR scanner
- Group 3: MR imaging on the Siemens Vida 3T MR scanner
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are people presently signing up to participate in this trial?
"That is correct, the clinical trial is listed as currently recruiting patients on clinicaltrials.gov. The trial was originally posted on September 1st, 2014 and was last updated on March 7th, 2022. The study is looking for 40 patients at 1 site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger